Lunts Healthcare Limited
12255844
Some Concerns
- No accounts filed in last 18 months (-5)
- 3 outstanding charges (-6)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 01/10/2021
PHARMACIST
BRITISH · ENGLAND · Age 47
Also on 14 other boards
Persons with Significant Control
R&A Nagra Ltd
30, Great Bridge, Tipton, DY4 7EW
Reg: 12667504 · Uk Companies House · Private Limited Company
Notified 01/10/2021
Former PSCs
Mr Martin James Lunt
Ceased 10/10/2019
J K Lunt Limited
Ceased 30/09/2021
Msn Pharm Ltd
Ceased 28/09/2020
Charges3 outstanding
LLOYDS BANK PLC
LLOYDS BANK PLC
LLOYDS BANK PLC
WESLEYAN BANK LIMITED
CompanyRankvs 1635+ SIC 47730 peers62
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2024
Net Worth
£889k
Balance sheet strength
Cash
£112k
Cash in the bank
Net Current Assets
£165k
Working capital
Current Assets
£370k
Current Liabilities
£205k
Fixed Assets
£734k
Debtors
£209k
Profit After Tax
-£5k
Tax at Year End(2021)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 1.81 | -£5k |
| 2023 | 1.12 | -£69k |
| 2022 | 0.86 | -£177k |
| 2021 | 1.56 | -£123k |
| 2020 | 7.50 | — |
Derived from filed accounts. Not audited figures.